Wealthfront’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $377K | Sell |
2,714
-293
| -10% | -$40.7K | ﹤0.01% | 413 |
|
|
2018
Q2 | $373K | Buy |
+3,007
| New | +$373K | ﹤0.01% | 408 |
|
|
2017
Q4 | – | Sell |
-2,038
| Closed | -$286K | – | 525 |
|
|
2017
Q3 | $286K | Buy |
+2,038
| New | +$286K | ﹤0.01% | 433 |
|
|
2017
Q2 | – | Sell |
-1,903
| Closed | -$231K | – | 479 |
|
|
2017
Q1 | $231K | Sell |
1,903
-395
| -17% | -$47.9K | ﹤0.01% | 394 |
|
|
2016
Q4 | $281K | Buy |
2,298
+217
| +10% | +$26.5K | 0.01% | 303 |
|
|
2016
Q3 | $255K | Buy |
+2,081
| New | +$255K | 0.01% | 313 |
|
|
2016
Q1 | – | Sell |
-2,335
| Closed | -$445K | – | 363 |
|
|
2015
Q4 | $445K | Buy |
2,335
+521
| +29% | +$99.3K | 0.02% | 158 |
|
|
2015
Q3 | $284K | Buy |
1,814
+351
| +24% | +$55K | 0.01% | 208 |
|
|
2015
Q2 | $264K | Sell |
1,463
-676
| -32% | -$122K | 0.01% | 212 |
|
|
2015
Q1 | $371K | Sell |
2,139
-4
| -0.2% | -$694 | 0.02% | 120 |
|
|
2014
Q4 | $397K | Buy |
2,143
+633
| +42% | +$117K | 0.02% | 87 |
|
|
2014
Q3 | $250K | Buy |
1,510
+257
| +21% | +$42.6K | 0.02% | 119 |
|
|
2014
Q2 | $206K | Buy |
1,253
+862
| +220% | +$142K | 0.02% | 104 |
|
|
2014
Q1 | $61K | Buy |
+391
| New | +$61K | 0.01% | 218 |
|